Get AI Briefings, Transcripts & Alerts on Local & National Government Meetings — Forever.
Treasurer's office proposes joining ArrayRx discount-card to lower drug costs; committee approves bill amendments
Summary
Treasury presenters described a plan for Vermont to join ArrayRx, a public multistate prescription discount-card program; they said the program could provide broad drug coverage with embedded small fees, and the Finance Committee voted 7-0 to report the enabling bill with an amendment and a $50,000 FY2027 appropriation.
A Treasury presentation to the Senate Finance Committee on May 1 proposed that Vermont join ArrayRx, a multistate, public-sector prescription discount-card collaborative that negotiates pricing and maintains a nationwide pharmacy network. "So what we are proposing is for Vermont to join a multistate collaborative known as ArrayRecs," the presenter said, describing a program used by Oregon and Washington and recently adopted by other states.
Peter Tremblay (director of legislative affairs) told the committee that even a small uptake could deliver meaningful savings: "If there were just 1 percent uptake ... that would be $20,000,000 more dollars per year back in Vermonters pockets," he said. Treasury and program presenters said average savings observed in other states are "up to 20% on brand name drugs and up to 80% on generics," and they stressed that enrollment would be free to residents.
Under the model described, a modest per-transaction fee would be embedded in the advertised price paid by the consumer; that fee funds ArrayRx operations and the PBM that administers transactions. The presenters said the program's governance is public-sector led (the Oregon Health Authority currently provides administrative staff) and that any funds left over after operating costs are redistributed to participating states into a special fund. The bill text would direct program revenue into the Financial Literacy and Economic Empowerment Trust Fund and includes a one-time FY2027 appropriation of $50,000 to help the treasurer's office with implementation work.
Committee members pressed the presenters on potential impacts to independent pharmacies and the transparency of the embedded fee. One senator noted a crowded market of private discount cards and low consumer uptake for some tools; presenters said ArrayRx includes online price-transparency tools that allow consumers to compare costs across pharmacies and that nothing in the bill forces a pharmacy to participate. The presenters also said the bill allows amounts paid through the card to be counted toward a consumer's deductible under insurance law changes included in the draft.
Legislative Council counsel and Treasury staff said the main implementation barrier is the state contracting process; presenters hope to complete contracting by the end of the year and launch the service in late 2026. The committee voted by voice to report the bill favorably with the Senate Health & Welfare amendment that adds pharmacy-impact reporting; the clerk recorded the vote as 7-0 in favor.
The treasurer's office and legislative counsel said they would provide additional details on PBM arrangements, steering-committee representation and projected year-one state receipts during the implementation process.
